Evaluation of the kinetics of the bone marrow tumor load in the course of sequential high-dose therapy assessed by quantitative PCR as a predictive parameter in patients with multiple myeloma

This publication has 13 references indexed in Scilit:

• Melphalan plus total body irradiation (MEL-TBI) or cyclophosphamide (MEL-CY) as a conditioning regimen with second autotransplant in responding patients with myeloma is inferior compared to historical controls receiving tandem transplants with melphalan alone
  Bone Marrow Transplantation, 2000
• Analysis of circulating tumor cells in patients with multiple myeloma during the course of high-dose therapy with peripheral blood stem cell transplantation
  Bone Marrow Transplantation, 1999
• CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH‐DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATION
  British Journal of Haematology, 1998
• Sequential analysis of bone marrow and peripheral blood after stem cell transplant for myeloma shows disparate tumor involvement
  Leukemia, 1997
• A quantitative PCR assay for the detection of low amounts of malignant cells in multiple myeloma
  Annals of Oncology, 1997
• A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple Myeloma
  New England Journal of Medicine, 1996
• Cellular origin and extent of clonal involvement in multiple myeloma: genetic and phenotypic studies
  British Journal of Haematology, 1994
• Development of a highly sensitive assay, based on the polymerase chain reaction, for rare B‐lymphocyte clones in a polyclonal population
  British Journal of Haematology, 1990
• Avoiding false positives with PCR
  Nature, 1989
• A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival
  Cancer, 1975